Ottmann works on small-molecule modulation or Protein-Protein Interactions (PPIs) with a special focus on stabilization or 14-3-3 adapter protein PPIs. He is also involved in several early drug discovery projects with the pharmaceutical industry, targeting disease as diverse as cancer, Alzheimer's disease, inflammation and cystic fibrosis.